<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00443144</url>
  </required_header>
  <id_info>
    <org_study_id>TS-TUE-FH1</org_study_id>
    <nct_id>NCT00443144</nct_id>
  </id_info>
  <brief_title>D3-GHR Polymorphism and Turner Syndrome</brief_title>
  <official_title>D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The protein polymorphism of the growth hormone receptor characterized by the genomic deletion
      of exon 3 has been linked to the magnitude of the first-year-growth response to growth
      hormone (GH) in girls with Turner syndrome.

      Objective: to study the long-term effect of GH therapy in Turner syndrome in correlation to
      this GHR polymorphism in a mainly retrospective design (chart-review).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Turner Syndrome</condition>
  <condition>Short Stature</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>recombinant human growth hormone</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Turner syndrome defined by a structural aberration or lack of the X chromosome.

          -  Growth velocity less than 2 cm/year at the time of final analysis (= final height).

        Exclusion Criteria:

          -  Age &lt;3.5 or &gt;14 years at start of GH therapy,

          -  GH peak serum levels &lt; 8 ng/ml in two independent tests,

          -  Thelarche at start or during the first year of treatment,

          -  Oxandrolone therapy for any time and a duration of GH therapy less than 2 years.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>38 Months</minimum_age>
    <maximum_age>14 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Binder, M.D. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University-Children's Hospital Tübingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University-Children's Hospital</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougnères P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet. 2004 Jul;36(7):720-4. Epub 2004 Jun 20.</citation>
    <PMID>15208626</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2007</study_first_submitted>
  <study_first_submitted_qc>March 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2007</study_first_posted>
  <last_update_submitted>December 2, 2015</last_update_submitted>
  <last_update_submitted_qc>December 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Gerhard Binder</investigator_full_name>
    <investigator_title>Pediatric Endocrinology</investigator_title>
  </responsible_party>
  <keyword>growth hormone receptor polymorphism</keyword>
  <keyword>pharmacogenomics</keyword>
  <keyword>growth promoting therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Turner Syndrome</mesh_term>
    <mesh_term>Gonadal Dysgenesis</mesh_term>
    <mesh_term>Primary Ovarian Insufficiency</mesh_term>
    <mesh_term>Dwarfism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

